An inherent problem in determining CYP1B1 activity in tumour tissue is that there are no truly specific assays to distinguish between CYP1A1, CYP1A2 and CYP1B1 activity, which show close homology with one another and overlapping substrate specificity. This evidence concerns the gene CYP1B1 and neoplasm.